How Gene Networks Can Uncover Novel CVD Players

Laurence D Parnell1, Patricia Casas-Agustench2, Lakshmanan K Iyer3

  • 1Nutritional Genomics Laboratory, JM-USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street, Boston, MA 02111.

Insights

Understanding cardiovascular diseases (CVD) involves mapping complex biological networks. Encompassing interactomes reveal novel CVD players and disease mechanisms for better prevention strategies.

Area of Science:

  • Cardiovascular biology
  • Systems biology
  • Network medicine

Background:

  • Cardiovascular diseases (CVD) are complex, multifactorial conditions.
  • Understanding the interplay of genes, molecules, and organ function is crucial for CVD research.
  • Current network classifications (e.g., lipids, inflammation) offer limited scope.

Purpose of the Study:

  • To demonstrate the utility of encompassing biological networks in understanding CVD.
  • To exemplify how network analysis can identify novel cardiovascular disease players.
  • To highlight the potential of systems-level approaches in CVD research.

Main Methods:

  • Construction and analysis of diverse biological networks.
  • Integration of various biological entities (genes, small molecules, organ function).
  • Network-based hypothesis generation for novel CVD factors.

Main Results:

  • Encompassing networks provide a more comprehensive view of CVD pathophysiology.
  • Network analysis facilitates the identification of previously unrecognized contributors to CVD.
  • The presented networks exemplify the potential for discovering new CVD-related biological entities.

Conclusions:

  • Holistic network approaches are more informative than narrowly classified interactomes for CVD.
  • Network medicine offers a powerful framework for uncovering novel CVD mechanisms and therapeutic targets.
  • Systems-level analysis is essential for advancing cardiovascular disease understanding and prevention.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.6K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.7K
Protein Networks02:26

Protein Networks

1.8K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.6K
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.6K